Stingeni L, Ravasio R, Palladino C, Di Fino S, Levi A, Ronci G, Gisondi P. Cost per responder of upadacitinib 30 mg and dupilumab 300 mg in patients with moderate-to-severe atopic dermatitis in italy. Grhta [Internet]. 2025 Mar. 10 [cited 2025 Mar. 12];12(1):70-9. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/3458